The TECHdotMN team would like to introduce you to each of the startups featured in the upcoming BETA showcase. Over the next couple of weeks, we will highlight each company, so you can get a better idea of the talent, hardwork, and dedication held within each of these startups.
The third featured company in our BETA Startup Showcase series is: Anatomi
Tell us the story of how and why your started your company.
Co-founders Patrick Walsh and Vince Truong had been working together on the fundamental technology behind Anatomi Corp for 5 years in the laboratories of Dr. James Dutton and Ann M. Parr while attempting to create new stem cell treatments for spinal cord injury. After plenty of hard work and numerous failures, they created a breakthrough in stem cell biology resulting in a platform technology that was more broadly applicable to accelerating the discovery of treatments to neurodegenerative conditions beyond spinal cord injury alone, and had to decide what next steps to take. Patrick’s previous industry experience inventing, patenting, and commercializing stem cell technologies helped him realize a business case could be built around the invention. Patrick and Vince then enrolled in the part-time MBA program at the Carlson School of Management to better understand the entrepreneurial path. They enrolled in the Discovery Launchpad business plan incubator at the University of Minnesota Venture Center, and after substantial coaching graduated from the program and decided to license the invention from the University to spin out Anatomi Corp.
What’s your most recent success or milestone hit?
Spin-out was feasible due to financing from the Regenerative Medicine Minnesota foundation, a granting agency funded by the state of Minnesota to support basic and applied stem cell biology, and commercialization of stem cell technologies within the state. This grant was awarded to Anatomi Corp to start up operations, perform customer discovery, and create initial sales. Anatomi Corp is currently launching its first product related to the study of chronic pain management in October, which has already been generating interest, with a potential sale pending.
Where do you see your startup one year from now?
Anatomi Corp will have celebrated its 18th month of existence, with growing sales based on its initial product offering. Furthermore, Anatomi Corp will be close to launching its second product, backed by an SBIR grant awarded from the National Institutes of Neurodegenerative Disease and Stroke (NINDS), related to the study of Parkinson’s Disease.
For more information, please visit: Anatomi Corp